CAS: 1346133-08-1

LY2795050 is a novel specific κ-Opioid Receptor antagonist (IC50: 0.72 nM).

LY2795050 is a drug that acts as a δ receptor agonist. It has been shown to have a number of pharmacokinetic and kinetic properties in humans, including the ability to cross the blood-brain barrier. LY2795050 has also been shown to increase locomotor activity in rats and is being studied for its potential use in the treatment of nervous system diseases such as Alzheimer's disease and Parkinson's disease. LY2795050 may be used to treat women with post-traumatic stress disorder (PTSD).

LY2795050